Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

327 ARTÍCULOS , VIENDO DEL 166 AL 180

Lack of association between cathepsin D C224T polymorphism and Alzheimer's disease risk: an update meta-analysis

Mo C, Peng Q, Sui J, Wang J, Deng Y, Xie L, Li T, He Y, Qin X, Li S.

BMC Neurol. 2014 Jan 15;14:13. doi: 10.1186/1471-2377-14-13.

Etiology and pathogenesis of late-onset Alzheimer's disease

Balin BJ, Hudson AP.

Curr Allergy Asthma Rep. 2014 Mar;14(3):417. doi: 10.1007/s11882-013-0417-1.

Molecular imaging in sporadic Alzheimer's disease populations and those genetically at risk

Nordberg A.

Neurodegener Dis. 2014;13(2-3):160-2. doi: 10.1159/000356333. Epub 2014 Jan 9.

Diagnosing Alzheimer's disease: update for the primary care clinician

Mendiratta P, Wei JY.

J Ark Med Soc. 2014 Jan;110(8):160-3.

Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial

Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.

JAMA. 2014 Feb 19;311(7):682-91. doi: 10.1001/jama.2014.93.

Development, validity, and reliability of the General Activities of Daily Living Scale: a multidimensional measure of activities of daily living for older people

Paula JJ, Bertola L, Ávila RT, Assis Lde O, Albuquerque M, Bicalho MA, Moraes EN, Nicolato R, Malloy-Diniz LF.

Braz J Psychiatry. 2014 Apr-Jun;36(2):143-52. doi: 10.1590/1516-4446-2012-1003. Epub 2014 Feb 4.

Functional brain connectivity using fMRI in aging and Alzheimer's disease

Dennis EL, Thompson PM.

Neuropsychol Rev. 2014 Mar;24(1):49-62. doi: 10.1007/s11065-014-9249-6. Epub 2014 Feb 23.

Advances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer's disease based on multi-modal MRI techniques

Hu Z, Wu L, Jia J, Han Y.

Neurosci Bull. 2014 Apr;30(2):198-206. doi: 10.1007/s12264-013-1407-y. Epub 2014 Feb 27.

Amyloid imaging in depression: a predictor of Alzheimer's disease?

Camacho V, Lleó A.

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):711-3. doi: 10.1007/s00259-014-2741-7.

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study

Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Joshi AD, Lu M, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ; AV45-A11 Study Group; AV45-A11 Study Group.

Mol Psychiatry. 2014 Sep;19(9):1044-51. doi: 10.1038/mp.2014.9. Epub 2014 Mar 11.

[Awareness disorders in Alzheimer's disease and in mild cognitive impairment]

Jacus JP, Dupont MP, Herades Y, Pelix C, Large H, Baud M.

Encephale. 2014 Apr;40(2):180-7. doi: 10.1016/j.encep.2013.10.003. Epub 2014 Mar 11.

Possible role of vascular risk factors in Alzheimer's disease and vascular dementia

Hasnain M, Vieweg WV.

Curr Pharm Des. 2014;20(38):6007-13. doi: 10.2174/1381612820666140314153440.

How are we going to live with Alzheimer's disease?

Karlawish J.

Health Aff (Millwood). 2014 Apr;33(4):541-6. doi: 10.1377/hlthaff.2014.0089.

Alzheimer's disease in African Americans: risk factors and challenges for the future

Barnes LL, Bennett DA.

Health Aff (Millwood). 2014 Apr;33(4):580-6. doi: 10.1377/hlthaff.2013.1353.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias